Business Insights have teamed up with IMS Health to bring you, The Diabetes Market Outlook: Market analysis of future growth and leading players by sector This unique product offering provides an analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, an unrivalled source of pharmaceutical intelligence on the diabetes market.
This report analyzes diabetes market dynamics and provides a country-by-country drug and brand analysis enabling you to assess product success/failure within US and European geographical markets. This report focuses on the market segmentation of key anti-diabetic drugs (insulin and oral anti-diabetic (OAD)), and also reviews the growth strategies of leading players in the diabetics market. Upcoming revolutionary products in development are also investigated, highlighting those expected to drive market growth in the future and transform the treatment options for diabetic patients.
Diabetes type 2 has now reached epidemic levels, affecting over 30 million people in the US and Europe, with this figure projected to rise to over 40 million by 2012. Rising rates of obesity and the increasing age demographic are key drivers of this epidemic. Ensure you maximize the opportunities presented by this demographic growth, drive product development and exploit new and existing revenue streams in this rapidly growing market.
View Cart
